Article
Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100.
Molecular pharmacology - 1 Jul 2001
Hatse S, Princen K, Gerlach L O, Bridger G, Henson G, De Clercq E, Schwartz T W, Schols D
Abstract excerpt
The bicyclam AMD3100 is a highly potent and selective CXCR4 antagonist with strong antiviral activity against human immunodeficiency virus (HIV)-1 and HIV-2, which use CXCR4 as coreceptor for host cell entry. Here, we investigated the interaction of AMD3100 with CXCR4 at the molecular level by mutational analysis. We established a set of stably transfected U87.CD4 cell lines expressing different mutant forms of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.